Concepedia

Nicholas C. Yoder

NC

Statistics

Publications

21

Citations

1.4K

H-Index

19

Active since

2005

Affiliations

ImmunoGen (United States)(Current)

Whitehead Institute for Biomedical Research

Tufts University

Johannes Gutenberg University Mainz

Massachusetts Institute of Technology

Nicholas C. Yoder is an author at ImmunoGen (United States) specializing in antibody-drug conjugates, antibody conjugates, and cancer pharmacology.

ORCID

Publications per year

2005–2025

21

Publications

21

Effects of Drug–Antibody Ratio on Pharmacokinetics, Biodistribution, Efficacy, and Tolerability of Antibody–Maytansinoid Conjugates

Xiuxia Sun, Jose F. Ponte, Nicholas C. Yoder et al. · Bioconjugate Chemistry · 2017 · 253 citations

, , +17

Site-Specific N- and C-Terminal Labeling of a Single Polypeptide Using Sortases of Different Specificity

John M. Antos, Guo-Liang Chew, Carla P. Guimarães et al. · Journal of the American Chemical Society · 2009 · 250 citations · Full text

, , +16

A CD123-targeting antibody-drug conjugate, IMGN632, designed to eradicate AML while sparing normal bone marrow cells

Yelena Kovtun, Gregory E. Jones, Sharlene Adams et al. · Blood Advances · 2018 · 176 citations · Full text

, , +15

Preparation of unnatural N-to-N and C-to-C protein fusions

Martin D. Witte, Juan J. Cragnolini, Stephanie K. Dougan et al. · Proceedings of the National Academy of Sciences · 2012 · 136 citations · Full text

, , +13

Understanding How the Stability of the Thiol-Maleimide Linkage Impacts the Pharmacokinetics of Lysine-Linked Antibody–Maytansinoid Conjugates

Jose F. Ponte, Xiuxia Sun, Nicholas C. Yoder et al. · Bioconjugate Chemistry · 2016 · 79 citations

, , +17

1–5 of 21